EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Planned Androgen-Deprivation Therapy Duration and Calculated 3-Year Major Osteoporotic Fracture Risk After Fracture Risk Assessment Tool Evaluation in Nonmetastatic Prostate Cancer: A Model-Based Analysis

Motohiro Fujiwara, Soichiro Yoshida, Shugo Yajima, Wei Chen, Hiroyuki Sato, Akihiro Hirakawa, Hiroshi Fukushima, Yuki Arita, Yosuke Yasuda, Minato Yokoyama, Yasuhisa Fujii

Cancer Treatment and Research Communications · 2026-11 · 101546

DOI: 10.1016/j.ctarc.2026.101546 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Treatment and Research Communications, 2026-11. Verfasst von Motohiro Fujiwara und 10 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Fujiwara, M., Yoshida, S., Yajima, S., Chen, W., Sato, H., Hirakawa, A., Fukushima, H., Arita, Y., Yasuda, Y., Yokoyama, M., & Fujii, Y. (2026). Planned Androgen-Deprivation Therapy Duration and Calculated 3-Year Major Osteoporotic Fracture Risk After Fracture Risk Assessment Tool Evaluation in Nonmetastatic Prostate Cancer: A Model-Based Analysis. Cancer Treatment and Research Communications, 101546. https://doi.org/10.1016/j.ctarc.2026.101546

Vancouver

Fujiwara M, Yoshida S, Yajima S, Chen W, Sato H, Hirakawa A, et al. Planned Androgen-Deprivation Therapy Duration and Calculated 3-Year Major Osteoporotic Fracture Risk After Fracture Risk Assessment Tool Evaluation in Nonmetastatic Prostate Cancer: A Model-Based Analysis. Cancer Treatment and Research Communications. 2026:101546. doi:10.1016/j.ctarc.2026.101546

BibTeX
@article{Fujiwara2026,
  author = {Fujiwara, Motohiro and Yoshida, Soichiro and Yajima, Shugo and Chen, Wei and Sato, Hiroyuki and Hirakawa, Akihiro and Fukushima, Hiroshi and Arita, Yuki and Yasuda, Yosuke and Yokoyama, Minato and Fujii, Yasuhisa},
  title = {Planned Androgen-Deprivation Therapy Duration and Calculated 3-Year Major Osteoporotic Fracture Risk After Fracture Risk Assessment Tool Evaluation in Nonmetastatic Prostate Cancer: A Model-Based Analysis},
  journal = {Cancer Treatment and Research Communications},
  year = {2026},
  pages = {101546},
  doi = {10.1016/j.ctarc.2026.101546}
}
Kostenlos starten →